The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...

TUESDAY, May 13, 2025 (HealthDay News) — U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya ...

The Trump administration's FDA and CDC is advising U.S. patients using the drug Ixchiq to hold off while U.S. health ...

The U.S. government is advising that international travelers age 60 and older not get a chikungunya vaccine as it ...

A study of more than one million people found the shingles vaccine may lower the risk of heart disease and stroke for up to ...

Fewer than half of Americans trust the government to respond to disease outbreaks , act independently, or ensure the safety ...

A new study suggests the shingles vaccine may reduce the risk of heart disease for up to eight years post-vaccination. A ...

More than 3,000 GPTs are reportedly in use at Moderna, which has partnered with OpenAI. Here's how they're using the technology.

In this study, those who had the Zostavax vaccine had a 3.5% point reduction in a new dementia diagnosis over seven years, ...

The CDC began recommending Ixchiq last year for adults traveling to countries where chikungunya is common. The vaccine uses a ...

Researchers found people given a shingles vaccine had a 23% lower risk of cardiovascular events, including stroke, heart ...

The shingles vaccine has benefits that stretch beyond protecting older adults from the painful skin condition, a new study ...